Results 161 to 170 of about 35,679 (203)

Crystal structures, crystal packing and supramolecular motifs in [Fe(phen)3]I14 and [M(phen)3]I18 (M⊕=⊕Fe, Ni): complementary orthogonality of [M(phen)3]2+ cations and polyiodide anions

CrystEngComm, 2001
The crystallisation, crystal structures, and crystal packing analyses of [Fe(phen)3]I14 and [Fe(phen)3]I18 are reported (phen⊕=⊕1,10-phenanthroline). [Ni(phen)3]I18 and [Fe(phen)3]I18 are isomorphous. These three compounds crystallise from iodine-rich solutions, and as crystals are relatively stable to loss of I2 over periods of weeks. Crystalline
Caitlin Horn, Ian Gordon Dance
exaly   +2 more sources

OLIVE ROOTSTOCKS TO CONTROL 'ARBEQUINA IRTA-I18' CLONE VIGOUR - RESULTS FROM A SECOND ONE COMPARATIVE TRIAL

Acta Horticulturae, 2014
A. Romero, J.F. Hermoso, J. Tous
exaly   +2 more sources

I18 Perk activation therapy in huntington’s disease

Experimental therapeutics – preclinical, 2018
Protein aggregation stands at the center of many neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis and Huntington’s disease (HD). HD is caused by a mutation in the huntingtin gene, resulting in expansion of poly-glutamine repeats, causing aggregation of the huntingtin protein in the cell.
Talya Shacham, Gerardo Lederkrember
openaire   +1 more source